Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.

作者: Xuan Yang , Derek Ammeter , Temilolu Idowu , Ronald Domalaon , Marc Brizuela

DOI: 10.1016/J.EJMECH.2019.05.003

关键词: RifampicinAntibioticsCiprofloxacinAdjuvantRifamycinMicrobiologyChemistryAminoglycosideMultiple drug resistanceTobramycin

摘要: Abstract The inability to discover novel class of antibacterial agents, especially against Gram-negative bacteria (GNB), compel us consider a broader non-conventional approach treat infections caused by multidrug-resistant (MDR) bacteria. One such is the use adjuvants capable revitalizing activity current existing antibiotics from resistant pathogens. Recently, our group reported series tobramycin (TOB)-based hybrid that were able potentiate multiple classes legacy various MDR GNB. Herein, we report modification TOB-based replacing TOB domain pseudo-disaccharide nebramine (NEB) through selective cleavage α- d -glucopyranosyl linkage TOB. Potent synergism was found for combinations NEB-based with including fluoroquinolones (moxifloxacin and ciprofloxacin), tetracyclines (minocycline), or rifamycin (rifampicin) both wild-type P. aeruginosa clinical isolates. We also demonstrated combination optimized NEB-CIP 1b rifampicin protects Galleria mellonella larvae lethal effects extensively drug-resistant (XDR) P. aeruginosa. Mechanistic evaluation revealed hybrids affect outer- inner membranes PAO1. This study describes an optimize aminoglycoside-based yield lead adjuvant candidates are resuscitate partner

参考文章(41)
J.H. Powers, Antimicrobial drug development – the past, the present, and the future Clinical Microbiology and Infection. ,vol. 10, pp. 23- 31 ,(2004) , 10.1111/J.1465-0691.2004.1007.X
Helio S. Sader, Mariana Castanheira, Rodrigo E. Mendes, Robert K. Flamm, David J. Farrell, Ronald N. Jones, Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in U.S. Medical Centers in 2012 and 2013 Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 3656- 3659 ,(2015) , 10.1128/AAC.05024-14
David J. Payne, Michael N. Gwynn, David J. Holmes, David L. Pompliano, Drugs for bad bugs: confronting the challenges of antibacterial discovery Nature Reviews Drug Discovery. ,vol. 6, pp. 29- 40 ,(2007) , 10.1038/NRD2201
D. Fourmy, M. I. Recht, S. C. Blanchard, J. D. Puglisi, Structure of the A Site of Escherichia coli 16S Ribosomal RNA Complexed with an Aminoglycoside Antibiotic Science. ,vol. 274, pp. 1367- 1371 ,(1996) , 10.1126/SCIENCE.274.5291.1367
George G Zhanel, Mel DeCorby, Nancy Laing, Barb Weshnoweski, Ravi Vashisht, Franil Tailor, Kim A Nichol, Aleksandra Wierzbowski, Patricia J Baudry, James A Karlowsky, Philippe Lagacé-Wiens, Andrew Walkty, Melissa McCracken, Michael R Mulvey, Jack Johnson, Canadian Antimicrobial Resistance Alliance (CARA), Daryl J Hoban, None, Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrobial Agents and Chemotherapy. ,vol. 52, pp. 1430- 1437 ,(2008) , 10.1128/AAC.01538-07
Linda Ejim, Maya A Farha, Shannon B Falconer, Jan Wildenhain, Brian K Coombes, Mike Tyers, Eric D Brown, Gerard D Wright, None, Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy Nature Chemical Biology. ,vol. 7, pp. 348- 350 ,(2011) , 10.1038/NCHEMBIO.559
Jürgen B. Bulitta, Neang S. Ly, Cornelia B. Landersdorfer, Nicholin A. Wanigaratne, Tony Velkov, Rajbharan Yadav, Antonio Oliver, Lisandra Martin, Beom Soo Shin, Alan Forrest, Brian T. Tsuji, Two Mechanisms of Killing of Pseudomonas aeruginosa by Tobramycin Assessed at Multiple Inocula via Mechanism-Based Modeling Antimicrobial Agents and Chemotherapy. ,vol. 59, pp. 2315- 2327 ,(2015) , 10.1128/AAC.04099-14
Myriam Ouberai, Farid El Garch, Antoine Bussiere, Mickael Riou, David Alsteens, Laurence Lins, Isabelle Baussanne, Yves F. Dufrêne, Robert Brasseur, Jean-Luc Decout, Marie-Paule Mingeot-Leclercq, The Pseudomonas aeruginosa membranes: A target for a new amphiphilic aminoglycoside derivative? Biochimica et Biophysica Acta. ,vol. 1808, pp. 1716- 1727 ,(2011) , 10.1016/J.BBAMEM.2011.01.014